ArriVent BioPharma (AVBP) Superinvestor holders
7 of the superinvestors we track hold ArriVent BioPharma (AVBP) in their latest 13F filings, $190M in total.
Summary
The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $136M, 16.4% of the portfolio.
In their latest quarter: 1 opened a new position, 4 added, 1 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Zhang Lei Hillhouse (HHLR Advisors) |
Held | 3,929,117 | $136M | 16.4% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 872,011 | $30M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 566,796 | $20M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 57,804 | $2M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 23,287 | $808,990 | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 21,517 | $747,500 | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 8,823 | $306,511 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 7 |
| Q1 2026 | 8 |
| Q4 2025 | 7 |
| Q3 2025 | 4 |
| Q2 2025 | 3 |
| Q1 2025 | 4 |
| Q4 2024 | 2 |
| Q3 2024 | 4 |
Questions about ArriVent BioPharma
Which superinvestors own ArriVent BioPharma?
7 of the superinvestors we track hold ArriVent BioPharma (AVBP) in their latest 13F filings, $190M in total. Zhang Lei, David Shaw, Steve Cohen, Two Sigma, Paul Tudor Jones, Cliff Asness.
Who is the largest superinvestor holder of AVBP?
The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $136M, 16.4% of the portfolio.
From ArriVent BioPharma's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.